Adamis Pharma (ADMP)
NASDAQ:ADMP

Adamis Pharma Stock Analysis & Ratings

Adamis Pharma Stock Analysis Overview

Smart Score
1
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Adamis Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

ADMP

ADMP Stock Stats

Previous Close$0.61
Open$0.61
Bid0 x 0
Ask0 x 0
Today’s Range$0.59 - $0.6133
52-Week Range$0.55 - $2.34
Volume1.37M
Average Volume5.16M
Market Cap$89.96M
Beta1.23
P/E Ratio-1.3
EPS-0.48
Earnings DateMar 31, 2022

Company Description

Adamis Pharma

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
Sector
Healthcare
Industry
Drug Manufacturers
CEO
Dennis J. Carlo
Employees
143
Website
www.adamispharmaceuticals.com
ISIN
US00547W2089
Address
11682 El Camino Real, San Diego, CA, 92130, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

ADMP FAQ

What was Adamis Pharma’s price range in the past 12 months?
Adamis Pharma lowest stock price was $0.55 and its highest was $2.34 in the past 12 months.
    What is Adamis Pharma’s market cap?
    Adamis Pharma’s market cap is $89.96M.
      What is Adamis Pharma’s price target?
      Currently, no data Available
      What do analysts say about Adamis Pharma?
      Adamis Pharma’s analyst rating consensus is a ‘Hold. This is based on the ratings of 1 Wall Streets Analysts.
        When is Adamis Pharma’s upcoming earnings report date?
        Adamis Pharma’s upcoming earnings report date is Mar 31, 2022 which is in 71 days.
          How were Adamis Pharma’s earnings last quarter?
          Adamis Pharma released its earnings results on Nov 22, 2021. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.04 by -$0.04.
            Is Adamis Pharma overvalued?
            According to Wall Street analysts Adamis Pharma’s price is currently Overvalued.
              Does Adamis Pharma pay dividends?
              Adamis Pharma does not currently pay dividends.
              What is Adamis Pharma’s EPS estimate?
              Adamis Pharma’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Adamis Pharma have?
              Adamis Pharma has 148,890,000 shares outstanding.
                What happened to Adamis Pharma’s price movement after its last earnings report?
                Adamis Pharma reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.04. Following the earnings report the stock price went down -10%.
                  Which hedge fund is a major shareholder of Adamis Pharma?
                  Among the largest hedge funds holding Adamis Pharma’s share is Greenlight Capital Inc. It holds Adamis Pharma’s shares valued at 284K.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis